Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A 30-Second ultrasound trick that could spot deadly blood clots?

NCT ID NCT07098546

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study tests whether a bedside ultrasound measurement called 'bubble time' can help diagnose pulmonary embolism (a blood clot in the lungs). Researchers will measure bubble time in 250 emergency department patients with suspected embolism and compare it to standard CT scans. The goal is to see if this quick, low-cost test can reliably identify the condition, potentially speeding up diagnosis and treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bedside ultrasound measuring right ventricular 'bubble time'
What this could lead to
If effective, this quick bedside test could speed up diagnosis of pulmonary embolism, potentially reducing reliance on CT scans and enabling faster treatment decisions.
What could go wrong
This is an early diagnostic study, not a treatment trial. The bubble time test may not prove accurate enough to replace standard imaging, and results may vary depending on the operator.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

250 people

The number who actually took part.

Started

Jul 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

1.000.000

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- All patients presenting to the emergency department with any symptoms, undergoing pulmonary CT angiography due to suspected pulmonary embolism or evaluated as having a strong likelihood of embolism when CT cannot be performed will be included in the study. Exclusion Criteria: * Patients under the age of 18 * Patients with a severe history of tricuspid insufficiency * Patients with a severe of pulmonary hypertension * Patients with a severe of right heart failure * Patients without an echocardiographic report approved by cardiology within 48 hours after emergency admission * Patients in whom ultrasonographic measurements cannot be performed * Patients who refuse diagnosis and treatment voluntarily

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Tanisal değerlilik are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Recep Tayyip Erdoğan Üniversitesi Rize Eğitim ve Araştırma Hastanesi

    Rize, Merkez, 53020, Turkey (Türkiye)